Sakai T, Yamamoto K, Yokota H, Hakozaki-Usui K, Hino F, Kato I
Takara Shuzo Co., Ltd., Biotechnology Research Laboratories, Shiga, Japan.
Clin Chem. 1990 Mar;36(3):474-6.
We devised a kit for use with automated analyzers, for assay of urinary free L-fucose by means of a newly isolated L-fucose dehydrogenase (EC 1.1.1.122), and we measured L-fucose in healthy subjects, cancer patients, and patients with other diseases. It takes 10 min to complete one assay. Absorbance and L-fucose concentration were linearly related up to at least 3.0 mmol/L, analytical recovery was 90-104%, and intra- and interassay coefficients of variation were less than 4.2% and 7.8%, respectively. The concentrations of L-fucose, corrected for creatinine, were significantly higher than those in healthy subjects in nine of 18 patients with gastric ulcers, 19 of 21 patients with cirrhosis of the liver, and 206 of 366 patients with some type of cancer, reflecting a changed L-fucose metabolism. Because urine specimens are analyzed and the test is rapid and inexpensive, this method may be suitable for mass screening for some kinds of cancer, cirrhosis, and gastric ulcers.
我们设计了一种与自动分析仪配套使用的试剂盒,用于借助新分离的L-岩藻糖脱氢酶(EC 1.1.1.122)测定尿游离L-岩藻糖,并对健康受试者、癌症患者及其他疾病患者的L-岩藻糖进行了测定。完成一次测定需要10分钟。吸光度与L-岩藻糖浓度在至少3.0 mmol/L范围内呈线性关系,分析回收率为90% - 104%,批内和批间变异系数分别小于4.2%和7.8%。校正肌酐后的L-岩藻糖浓度,在18例胃溃疡患者中的9例、21例肝硬化患者中的19例以及366例某种癌症患者中的206例,均显著高于健康受试者,这反映了L-岩藻糖代谢的改变。由于对尿液标本进行分析,且该检测快速、成本低,因此该方法可能适用于某些癌症、肝硬化和胃溃疡的大规模筛查。